4AB:ETR
AbbVie Common Stock
239,10 €
arrow_upward
+0,97%(+2,30) 1D
7-окт., 13:17:53 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
238,20 €
High
239,60 €
Low
238,00 €
Mkt. cap
466,06 млд
Avg. vol.
672,00
Volume
99,00
52-wk high
239,60 €
52-wk low
162,85 €
No. of employees
57 миң
Open
238,20 €
High
239,60 €
Low
238,00 €
Mkt. cap
466,06 млд
Avg. vol.
672,00
Volume
99,00
52-wk high
239,60 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
Yahoo Finance
·
12 саат мурун
AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?
The Globe and Mail
·
22 саат мурун
Should You Buy AbbVie Stock Before Oct. 30?
Investing.com
·
22 саат мурун
UBS reiterates Abbvie stock rating on positive cancer trial data
Simply Wall Street
·
1 күн мурун
Did Frontline Lymphoma Trial Success Just Shift AbbVie (ABBV) Stock Narrative?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com